I am a PhD student at the University of Toronto in Canada and a co-founding member of the Psychedelic Science Interest Group. We are a team of early career psychiatrists, PhD students, and faculty currently researching on the benefits and drawbacks of microdosing psychedelics. Our early work relies on collecting data from existing microdosers to build a scientific understanding of potential outcomes of microdosing. Our upcoming research will involve running lab-based randomized-control trials where psychedelics are administered in controlled environments. This will help us better characterize the therapeutic and cognitive-enhancing effects of psychedelics, even in very small doses. My particular involvement is one focussed on ensuring methodological rigour and proper practice under open science. I also have research experience studying attention, meditation, and electrophysiological methods. I am supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).